BIO-FD&C Co.,Ltd. (KOSDAQ:251120)
South Korea · Delayed Price · Currency is KRW 8,550.00
-340.00 (-3.82%)
At close: Nov 6, 2026
BIO-FD&C Market Cap
BIO-FD&C has a market cap or net worth of 74.35 billion as of November 5, 2026. It is the 28,871st most valuable company in the world and the 1,403rd biggest in South Korea. Its market cap has decreased by 46.16% in one year.
Market Cap
74.35B
Enterprise Value
19.10B
Revenue
19.53B
Global Rank
Country Rank
#1,403 South Korea
PE Ratio
11.40
ChartMarket Cap Chart
Since February 21, 2022, BIO-FD&C's market cap has decreased from 193.04B to 74.35B, a decrease of -61.49%. That is a compound annual growth rate of -18.34%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 74.35B | -45.89% |
| Dec 30, 2025 | 137.39B | 14.33% |
| Dec 30, 2024 | 120.17B | -2.12% |
| Dec 28, 2023 | 122.78B | -16.94% |
| Dec 29, 2022 | 147.83B | -23.42% |
| Feb 21, 2022 | 193.04B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cell Biotech | 101.02B |
| ViGenCell | 92.55B |
| Prestige Biologics | 90.19B |
| Choong Ang Vaccine Laboratory | 83.22B |
| CHOOLIP & SCIENCES | 75.38B |
| EyeGene | 73.14B |
| CORESTEMCHEMON | 71.02B |
| Naturalendo Tech | 65.04B |